drugset / Trial / NCT06865040

Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in Patients at High Risk of Postoperative Pulmonary Complications

NCT06865040

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The objective of the study is to evaluate, in a clinical trial, the efficacy of peri operative administration of long-acting inhaled ß-2 mimetics on the occurrence of postoperative pulmonary complications

Timeline

Start
2025-07-31
Primary completion
2028-03
Completion
2028-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Formoterol Other / unclassified 12 ug Inhaled

Indications

No indication recorded.